glp-1 and breast cancer GLP-1s in Oncology: Nursing Insights Survivorship GLP-1s show 'encouraging' benefit in

Personalized Treatment Options Available At Cape Fear Physical Medicine.

In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)

On December 22, 2025, the FDA approved Novo Nordisks once-daily [...]

Understand the GLP-1 mechanism behind Ozempic and how it helps manage blood sugar, control appetite, and aid in weight loss using semaglutide.

Based on this review, evidence from head-to-head and insulin-comparator trials demonstrates that dual GIP/GLP-1 co-agonism consistently overcomes metabolic plateaus that result from single-pathway therapy, producing superior glycated hemoglobin reduction, bariatric-level weight loss (up to 25.3%), and robust macrovascular and heart failure protection, including a 38% reduction in composite cardiovascular risk among patients with heart failure with preserved ejection fraction (HFpEF)

This once-weekly weight loss injection works by suppressing the appetite- so you feel full longer.